|
Volumn 8, Issue 9, 2003, Pages 380-381
|
Superpeptide to treat Candida albicans
a
a
NONE
|
Author keywords
Alpha melanocyte stimulating hormone; Candida albicans; Drug Discovery; Immunology; Molecular Medicine; Peptide; Pharmaceutical Science; Yeast cells
|
Indexed keywords
ALPHA INTERMEDIN;
ANTIINFLAMMATORY AGENT;
CYCLIC AMP;
CYSTEINE;
CZEN 002;
FLUCONAZOLE;
PEPTIDE DERIVATIVE;
RECEPTOR PROTEIN;
ANTIBACTERIAL ACTIVITY;
ANTIINFLAMMATORY ACTIVITY;
ANTIMICROBIAL ACTIVITY;
ANTIPYRETIC ACTIVITY;
CANDIDA ALBICANS;
CANDIDA GLABRATA;
CANDIDA KEFYR;
CANDIDA KRUSEI;
CANDIDA PARAPSILOSIS;
CANDIDA TROPICALIS;
CANDIDIASIS;
CARBOXY TERMINAL SEQUENCE;
CLINICAL TRIAL;
DRUG POTENCY;
EXPERIMENTAL TEST;
FUNGICIDAL ACTIVITY;
HUMAN;
INFECTION CONTROL;
NONHUMAN;
SHORT SURVEY;
STAPHYLOCOCCUS AUREUS;
UNITED STATES;
VAGINITIS;
YEAST CELL;
ALPHA-MSH;
ANTIFUNGAL AGENTS;
CANDIDA ALBICANS;
CANDIDIASIS;
CLINICAL TRIALS;
DRUG RESISTANCE, FUNGAL;
FEMALE;
HUMANS;
|
EID: 0037403527
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(03)02684-9 Document Type: Short Survey |
Times cited : (7)
|
References (3)
|